This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wärnberg, F. Articles by Holmberg, L. Search for Related Content PubMed PubMed Citation Articles by Wärnberg, F. Articles by Holmberg, L.

Prognosis in Women with a Carcinoma in Situ of the Breast: A Population-based Study in Sweden¹

Departments of Surgery [F. W., L. H.] and Oncology [J. B.], University Hospital, S-751 85 Uppsala, Sweden

We studied the risk of invasive breast cancer and breast cancer death after a breast carcinoma in situ during a period when mammography screening became a nationwide practice and when breast conservation was introduced.

In a study base including all 4661 women registered to the Swedish Cancer Registry for a first carcinoma in situ between 1960 and 1992, we selected a cohort of 3398 women diagnosed between 1980 and 1992. The recruitment period was chosen according to the reporting routines for the registry.

The corrected survival was 97.4% after 10 years. The risk of invasive cancer was similar in the ipsilateral and contralateral breast. Women diagnosed between 1989 and 1992 ran a relative risk of 0.1 (95% confidence interval, 0.0–0.9) of dying of breast cancer, as compared with women diagnosed from 1980–1982. Residence in counties where mammography screening was available was associated with a relative risk of 0.2 (95% confidence interval, 0.0–2.1) for breast cancer death in the age groups screened.

Screening mammography may have contributed to the improvement of prognosis over this time period. This study cannot distinguish between lead time effects and a "true" improvement in prognosis. The increased use of breast conservation was not associated with a worse prognosis in the group as a whole. The study indicates that at least 50% of invasive cancers occurring after treatment for in situ lesions may be new cancers.

This article has been cited by other articles:

				V. L. Ernster, R. Ballard-Barbash, W. E. Barlow, Y. Zheng, D. L. Weaver, G. Cutter, B. C. Yankaskas, R. Rosenberg, P. A. Carney, K. Kerlikowske, et al. Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography J Natl Cancer Inst, October 16, 2002; 94(20): 1546 - 1554. [Abstract] [Full Text] [PDF]

				F. Wärnberg, J. Bergh, M. Zack, and L. Holmberg Risk Factors for Subsequent Invasive Breast Cancer and Breast Cancer Death after Ductal Carcinoma in Situ: A Population-based Case-Control Study in Sweden Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 495 - 499. [Abstract] [Full Text]